to the primary arthroplasty has increased [8] . A number of external studies have investigated the 81 validity of data within the NJR [8, 9] . 82
In comparison, the American Joint Replacement Registry (AJRR) is in its infancy. Since its inception in 83 2010, it has documented approximately ~550,000 joint arthroplasties, only representing 7-8% of 84 those implanted [6] . 85
The NJR [10] has been able to show the trends in fixation, bearing surfaces, demographics and 86 complications. 87
Fixation 88
The changing use of implant fixation has been documented and observed. at 1%. This decline coincided with more favourable use of ceramic-on-ceramic (CoC) and ceramic-97 on-polyethylene (CoP) bearings. Metal-on-polyethylene (MoP) has consistently remained a widely 98 used bearing surface, currently the most popular at 40% usage. 99
The trends in bearing surface utilisation on the NJR reflects known changes in practice such as the 100 decline of MoM hips in 2007 following widespread concern in the orthopaedic community and the 101 re-adoption of polyethylene bearings with use of highly cross linked polyethylene. The increased use 102 of ceramic femoral heads maybe due to concerns regarding taperosis and higher patient demands in 103 both the UK and USA. 104
Revision Rates 105
The emergence of highly cross linked polyethylene has seen a dramatic reduction in revision rate for 106 loosening. There is a danger of using large observational data series to make erroneous conclusions. 149
Correlations can be identified but causation cannot be concluded. For example, 'people with grey 150 hair have a higher risk of cancer' therefore 'grey hair causes cancer'. Clearly these statements hold 151 no scientific merit but misinterpreting observational data is commonplace, particularly to make 152 headlines in the lay press. 153
It is a valid observation that patients taking anti-epileptics have a 50 times greater risk of having a 154 seizure than a matched population. Figure 6 . They are confounded by their indication [18] There is 155 a four times risk of dying in the three months following stopping a statin. The risks and benefits of 156 statins extend beyond the scope of an orthopaedic readership but why would a physician stop a low 157 risk preventative medication? Figure 7 . This observation is confounded by patients being placed on 158 a palliative care pathway for terminal illness. Similarly the risk of rheumatoid arthritis is five times 159 greater in NSAID takers and the risk of being hospitalised with pneumonia is nine times higher in 160 patients prescribed amoxicillin. On a lighter note, if you have seen a doctor, the risk of dying within 161 the next two weeks is 30 times higher! Table 1 . 162
There is always some confounding and when analysing observational data it is important to consider 163 this especially if the authors are biased towards an exciting headline. 164
Orthopaedic data comparison is often age matched but within our scope of practise we see 70 year 165 olds running marathons and 50 year olds walking 10 yards with a Zimmer frame. Patient expectation 166 is multifactorial and can not be easily statistically controlled for. Revision rate particularly of an 167 implant perceived to be easily revised may be increased, not because it is mechanically inferior or 168 defective but because its indication is in high functioning, high demand patients. However this 169 rationale was used by metal on metal hip manufacturers to defend a product which we subsequently 170 know has design concerns. 171
Conclusion 172
In summary, registry data and large datasets can be an asset to arthroplasty surgeons, 173 manufacturers and policy makers to identify trends and outcomes. The NJR is successful due to 174 widespread adoption and auditing to ensure high quality, representative data is reported. 175
Analysis of the NJR has highlighted that total hip arthroplasty in young patients lags behind surgeons 176 and policy maker's expectations. 
